NO20040601L - Fremgangsmate for fremstilling av piroxicam: beta-cyklodekstrin-inklusjonsforbindelser - Google Patents
Fremgangsmate for fremstilling av piroxicam: beta-cyklodekstrin-inklusjonsforbindelserInfo
- Publication number
- NO20040601L NO20040601L NO20040601A NO20040601A NO20040601L NO 20040601 L NO20040601 L NO 20040601L NO 20040601 A NO20040601 A NO 20040601A NO 20040601 A NO20040601 A NO 20040601A NO 20040601 L NO20040601 L NO 20040601L
- Authority
- NO
- Norway
- Prior art keywords
- piroxicam
- beta
- preparation
- inclusion compounds
- cyclodextrin inclusion
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 229920000858 Cyclodextrin Polymers 0.000 title abstract 2
- 239000001116 FEMA 4028 Substances 0.000 title abstract 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 title abstract 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 title abstract 2
- 229960004853 betadex Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002702 piroxicam Drugs 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 229960000074 biopharmaceutical Drugs 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 230000008014 freezing Effects 0.000 abstract 1
- 238000007710 freezing Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Foreliggende oppfinnelse vedrører en fremgangsmåte for fremstilling av inklusjonsforbindelser for. piroxicam med P-syklodekstrin. Nærmere bestemt, ifølge fremgangsmåten ved oppfinnelsen, blir den vandige løsningen av to bestanddeler utsatt for en fryseprosess før tørking ved svært høy hastighet. De resulterende produktene har fysiko-kjemiske egenskaper så vel som teknologiske og biofarmasøytiske egenskaper som er fordelaktige sammenlignet med de oppnådd ifølge tidligere kjent fremgangsmåte. De resulterende produktene er egnet for fremstilling av farmasøytiske sammensetninger for oral administrasjon.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02013251A EP1374906B1 (en) | 2002-06-17 | 2002-06-17 | A process for the preparation of piroxicam: beta-cyclodextrin inclusion compounds |
| PCT/EP2003/006142 WO2003105906A1 (en) | 2002-06-17 | 2003-06-12 | A process for the preparation of piroxicam: b-cyclodextrin inclusion compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20040601L true NO20040601L (no) | 2004-02-10 |
| NO332262B1 NO332262B1 (no) | 2012-08-13 |
Family
ID=29716770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20040601A NO332262B1 (no) | 2002-06-17 | 2004-02-10 | Fremgangsmate for fremstilling av piroxicam: beta-cyklodekstrin-inklusjonsforbindelser |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7700579B2 (no) |
| EP (2) | EP1374906B1 (no) |
| KR (1) | KR101079484B1 (no) |
| CN (1) | CN100352444C (no) |
| AT (1) | ATE359827T1 (no) |
| AU (1) | AU2003245931A1 (no) |
| CA (1) | CA2489708A1 (no) |
| CY (1) | CY1107693T1 (no) |
| DE (1) | DE60219609T2 (no) |
| ES (1) | ES2286177T3 (no) |
| HR (1) | HRP20041192B1 (no) |
| IL (1) | IL165797A0 (no) |
| JO (1) | JO2533B1 (no) |
| MA (1) | MA27367A1 (no) |
| MX (1) | MXPA04012502A (no) |
| MY (1) | MY134691A (no) |
| NO (1) | NO332262B1 (no) |
| PL (1) | PL218414B1 (no) |
| PT (1) | PT1374906E (no) |
| RU (1) | RU2316350C2 (no) |
| SA (1) | SA03240220B1 (no) |
| SI (1) | SI1374906T1 (no) |
| TN (1) | TNSN04245A1 (no) |
| TW (1) | TWI341731B (no) |
| WO (1) | WO2003105906A1 (no) |
| ZA (1) | ZA200410142B (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2868315B1 (fr) * | 2004-04-01 | 2006-07-14 | Pierre Fabre Medicament Sa | Procede de preparation d'un compose d'inclusion soluble de substances actives dans une molecule hote avec l'aide d'un agent d'interaction par fluide supercritique |
| FR2876911B1 (fr) * | 2004-10-21 | 2007-04-13 | Pierre Fabre Medicament Sa | Complexe comprenant du piroxicam, une cyclodextrine et de l'arginine |
| ATE504316T1 (de) * | 2004-04-01 | 2011-04-15 | Pf Medicament | Einschlusskomplexe enthaltend piroxicam, ein cyklodextrin und arginin |
| CN101002782B (zh) * | 2007-01-10 | 2010-05-19 | 南京师范大学 | 含有头孢呋辛酯环糊精包合物的药物组合物及其制备方法 |
| CN101264087B (zh) * | 2007-03-14 | 2010-10-27 | 南京师范大学 | 含有头孢泊肟酯环糊精包合物的药物组合物及其制备方法 |
| HRP20180904T1 (hr) | 2010-08-04 | 2018-08-24 | Grünenthal GmbH | Farmaceutski oblik doziranja koji sadrži 6'-fluoro-(n-metil-ili n,n-dimetil-)-4-fenil-4',9'-dihidro-3'h-spiro[cikloheksan-1,1'-pirano[3,4,b]indol]-4-amin za liječenje neuropatske boli |
| EP2726106B1 (en) | 2011-07-01 | 2015-07-29 | Fondazione Istituto Insubrico di Ricerca per la Vita | A complex of amorphous tomoxiprole and cyclodextrin with fast dissolution rate and process for the preparation thereof |
| US20130310385A1 (en) | 2012-05-18 | 2013-11-21 | Gruenenthal Gmbh | Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants |
| US9320729B2 (en) | 2012-05-18 | 2016-04-26 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative |
| US8912226B2 (en) | 2012-05-18 | 2014-12-16 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r) -6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSAR |
| US20130310435A1 (en) | 2012-05-18 | 2013-11-21 | Gruenenthal Gmbh | Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol |
| US9855286B2 (en) | 2012-05-18 | 2018-01-02 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component |
| US9308196B2 (en) * | 2012-05-18 | 2016-04-12 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1 r,4r) -6'-fluoro-N ,N-dimethyl-4-phenyl-4',9'-d ihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1196033B (it) * | 1984-02-22 | 1988-11-10 | Chiesi Farma Spa | Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche |
| IT1204725B (it) * | 1987-06-17 | 1989-03-10 | Edmond Pharma Srl | Complessi di inclusione del dipiridamolo con ciclodestrine |
| EP0518930A4 (en) * | 1990-03-02 | 1993-09-15 | Australian Commercial Research & Development Limited | Cyclodextrin compositions and methods for pharmaceutical and industrial applications |
| US5164379A (en) * | 1991-07-15 | 1992-11-17 | Bristol-Myers Company | Sucralfate/cyclodextrin complexes |
| IT1269578B (it) * | 1994-04-22 | 1997-04-08 | Chiesi Farma Spa | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base. |
| DE19922572A1 (de) * | 1999-05-17 | 2000-11-23 | Bayer Ag | Verfahren zur Reinigung von organischen Isocyanaten, die so gereinigten organischen Isocyanate und ihre Verwendung |
-
2002
- 2002-06-17 AT AT02013251T patent/ATE359827T1/de active
- 2002-06-17 ES ES02013251T patent/ES2286177T3/es not_active Expired - Lifetime
- 2002-06-17 DE DE60219609T patent/DE60219609T2/de not_active Expired - Lifetime
- 2002-06-17 PT PT02013251T patent/PT1374906E/pt unknown
- 2002-06-17 SI SI200230568T patent/SI1374906T1/sl unknown
- 2002-06-17 EP EP02013251A patent/EP1374906B1/en not_active Expired - Lifetime
-
2003
- 2003-06-12 MX MXPA04012502A patent/MXPA04012502A/es active IP Right Grant
- 2003-06-12 AU AU2003245931A patent/AU2003245931A1/en not_active Abandoned
- 2003-06-12 HR HRP20041192AA patent/HRP20041192B1/hr not_active IP Right Cessation
- 2003-06-12 US US10/516,945 patent/US7700579B2/en not_active Expired - Lifetime
- 2003-06-12 EP EP03738016A patent/EP1513556B1/en not_active Expired - Lifetime
- 2003-06-12 WO PCT/EP2003/006142 patent/WO2003105906A1/en not_active Ceased
- 2003-06-12 KR KR1020047008384A patent/KR101079484B1/ko not_active Expired - Lifetime
- 2003-06-12 RU RU2004136988/15A patent/RU2316350C2/ru active
- 2003-06-12 CN CNB038173565A patent/CN100352444C/zh not_active Expired - Lifetime
- 2003-06-12 PL PL373873A patent/PL218414B1/pl unknown
- 2003-06-12 CA CA002489708A patent/CA2489708A1/en not_active Abandoned
- 2003-06-15 JO JO200367A patent/JO2533B1/en active
- 2003-06-16 MY MYPI20032243A patent/MY134691A/en unknown
- 2003-06-16 TW TW092116236A patent/TWI341731B/zh not_active IP Right Cessation
- 2003-07-27 SA SA03240220A patent/SA03240220B1/ar unknown
-
2004
- 2004-02-10 NO NO20040601A patent/NO332262B1/no not_active IP Right Cessation
- 2004-12-10 TN TNP2004000245A patent/TNSN04245A1/en unknown
- 2004-12-15 ZA ZA200410142A patent/ZA200410142B/xx unknown
- 2004-12-16 IL IL16579704A patent/IL165797A0/xx unknown
- 2004-12-17 MA MA28012A patent/MA27367A1/fr unknown
-
2007
- 2007-07-09 CY CY20071100907T patent/CY1107693T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1107693T1 (el) | Μεθοδος παρασκευης ενωσεων εγκλεισμου πιροξικαμησ:β-κυκλοδεξτρινης | |
| NO20070669L (no) | Fremgangsmate for fremstillingen av en prioksikam: betacyklodekstrininklusjonsforbindelse | |
| MY142029A (en) | Phenoxyacetic acid derivatives | |
| WO2000061568A8 (de) | Mit zuckerresten substituierte 1,4-benzothiazepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
| WO2002101412A3 (en) | Spray freeze-dried compositions | |
| WO2007009656A3 (de) | Neues 1,4-benzothiazepin-1,1-dioxidderivat mit verbesserten eigenschaften, verfahren zu dessen herstellung, diese verbindung enthaltende arzneimittel und dessen verwendung | |
| EP1389616A4 (en) | NEW BENZYL PIPERIDINE COMPOUND | |
| MEP9309A (en) | Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same | |
| ATE424384T1 (de) | Imidazolderivate, verfahren zu deren herstellung und deren anwendungen | |
| WO2004106307A3 (fr) | Nouveaux derives d’imidazoles, leur preparation et leur utilisation en tant que medicament | |
| IL166057A0 (en) | Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments | |
| CY1107362T1 (el) | Παραγωγα ιμιδαζολυλιου χρησιμα ως συνδετες υποδοχεων ισταμινης h3 | |
| ATE308537T1 (de) | Neue 1-amidomethylcarbonyl-piperidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| ATE269352T1 (de) | 4-benzylaminochinoline konjugate mit gallensaeure und ihre heteroanalogen, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und deren anwendung | |
| UA95088C2 (ru) | Композиция, которая содержит наночастички связанные с биосовместимым полимером противоракового агента и снижает аллопецию при химиотерапии, способ ее получения | |
| WO2001081298A3 (en) | Cyclic carboxylic acids as integrin antagonists | |
| TW200505892A (en) | Substituted 3-(benzoylureido)thiophene derivatives, processes for preparing them and their use | |
| WO2005021541A3 (en) | Process for the production of polymorphs of rosiglitazone maleate | |
| WO2003004460A3 (en) | Succinic acid derivatives | |
| NO331205B1 (no) | Farmasoytisk sammensetning som fast doseringsform og fremgangsmate for fremstilling derav | |
| WO2006099940A8 (de) | Substituierte, bizyklische 8-pyrrolidino-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| WO2002083641A3 (en) | Amino-aza-cyclohexanes for the treatment of malaria | |
| WO2003029495A3 (de) | Coniosulfide und deren derivate, verfahren zur ihrer herstellung und verwendung als arzneimittel | |
| WO2003013530A3 (de) | Salze substituierter 1,2,3,4,-tetrahydrochinolin-2-carbonsaurederivate als nmda-antagonisten | |
| WO2004018481A3 (fr) | Derives du gossypol, leurs procedes d'obtention, et leurs utilisations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |